Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,974.40
(
0.78%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
95.08
(
0.07%
)
Bitcoin
78,028.31
(
2.23%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Protector

Send PM Follow Ignore
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Protector

Re: corporalagarn post# 260405

Friday, 04/01/2016 10:09:04 AM

Friday, April 01, 2016 10:09:04 AM

Post# of 347009
corporal, you are jumping into the wrong conclusion.

We are talking about a transition here and the list contained the so wanted 'up-front cash' deal by many posters.

In all cases the end station is that Bavituximab end up in a combo and I don't see how this screws us.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote